Response to “A meta‐analysis comparing higher and lower dose radiotherapy for palliation in locally advanced lung cancer”

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|106|6|783-783

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.6, 2015-06, pp. : 783-783

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Meta‐analysis comparing higher and lower dose radiotherapy for palliation in locally advanced lung cancer

By  

Cancer Science, Vol. 106, Iss. 6, 2015-06 ,pp. : 782-782

John Wiley & Sons Inc

Access to resources Recommend Favorite

Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non‐small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX‐Lung 3

By  

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1202-1211

John Wiley & Sons Inc

Access to resources Recommend Favorite

Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non‐small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX‐Lung 3

By  

Cancer Science, Vol. 106, Iss. 9, 2015-09 ,pp. : 1202-1211

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II trial of chemoradiotherapy with S‐1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)

By  

Cancer Science, Vol. 106, Iss. 6, 2015-06 ,pp. : 726-733

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multimodality Treatment of Locally-Advanced Breast Cancer Using 6.3 MeV Fast Neutrons and Quality of Life in Patients in Long-Term Follow-Up

By  

Advanced Materials Research, Vol. 2015, Iss. 1084, 2015-02 ,pp. : 406-408

Trans Tech Publications

Access to resources Recommend Favorite